Evotec at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Evotec takes part in 2 sessions at ACT 2026 in San Antonio. Its program pairs machine learning with regulatory strategy. It covers a two-stage machine learning approach to predict on-target toxicity, and how drug developers can meet corporate goals as regulation grows more complex.

OrganizationACT 2026 Attendance
Evotec
Hamburg, Germany
evotec.com
Contract research organizations (CROs)
Drug discovery and development partner selling integrated research services to biotech and pharma, including ADME-toxicology through its Cyprotex unit.
Poster
Mon Nov 16
5:00pm–6:30pm
A Two-Stage Machine Learning Approach to Predict On-Target Toxicity (P506)
Nelson Exhibit Ballroom · Poster P506
In silico and AI
Talk
Tue Nov 17
12:00pm–12:55pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Evotec

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction